SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Total Assets

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) (BCYPU) currently reports a total assets of $240M as of June 2026. That compares with $30M in the prior-year period — up 690.6% year over year. Use the charts on this page to explore SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt)'s total assets history and peer comparisons.

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt)'s total assets increased from $30M to $240M — a 690.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) reported $240M in total assets as of June 2026. That compares with $30M in the prior-year period — up 690.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt), and consider following BCYPU for alerts when major investors trade the stock.